Technical Analysis for CUR - Neuralstem, Inc.

Grade Last Price % Change Price Change
grade C 0.5991 -7.12% -0.05
CUR closed down 7.12 percent on Friday, March 22, 2019, on 1.16 times normal volume.

Earnings due: Apr 1

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CUR trend table...

Date Alert Name Type % Chg
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Calm After Storm Range Contraction -7.12%
Mar 21 Stochastic Reached Overbought Strength -7.12%
Mar 21 Inside Day Range Contraction -7.12%
Mar 21 Wide Bands Range Expansion -7.12%
Mar 21 Above Upper BB Strength -7.12%
Mar 21 Overbought Stochastic Strength -7.12%
Mar 21 Upper Bollinger Band Touch Strength -7.12%

Older signals for CUR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. Its stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons. Its products under development include NSI – 566, which has completed Phase I clinical trial for the proposed treatment of amyotrophic lateral sclerosis, as well as for chronic spinal cord injury and motor deficits due to ischemic stroke; and NSI – 189, a small molecule pharmaceutical compound, which is in Phase Ib clinical trial for the treatment of major depressive disorder. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
Biotechnology Biopharmaceutical Life Sciences Biology Stem Cells Amyotrophic Lateral Sclerosis Major Depressive Disorder Stem Cell Therapy Treatment Of Major Depressive Disorder Ischemic Stroke
Is CUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.05
52 Week Low 0.25
Average Volume 260,936
200-Day Moving Average 0.8169
50-Day Moving Average 0.4647
20-Day Moving Average 0.5298
10-Day Moving Average 0.5613
Average True Range 0.0573
ADX 30.34
+DI 29.5202
-DI 11.9252
Chandelier Exit (Long, 3 ATRs ) 0.5180999999999999
Chandelier Exit (Short, 3 ATRs ) 0.6019
Upper Bollinger Band 0.6347
Lower Bollinger Band 0.4249
Percent B (%b) 0.83
BandWidth 39.599849
MACD Line 0.0383
MACD Signal Line 0.0295
MACD Histogram 0.0088
Fundamentals Value
Market Cap 7.26 Million
Num Shares 12.1 Million
EPS -2.22
Price-to-Earnings (P/E) Ratio -0.27
Price-to-Sales 977.06
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.72
Resistance 3 (R3) 0.73 0.69 0.70
Resistance 2 (R2) 0.69 0.66 0.69 0.69
Resistance 1 (R1) 0.65 0.64 0.63 0.64 0.69
Pivot Point 0.61 0.61 0.61 0.61 0.61
Support 1 (S1) 0.57 0.58 0.55 0.56 0.51
Support 2 (S2) 0.53 0.56 0.53 0.51
Support 3 (S3) 0.49 0.53 0.50
Support 4 (S4) 0.48